Hauber AB - Search Results

1

Understanding the relative importance of preserving functional abilities in Alzheimer's disease in the United States and Germany.

Hauber AB, Mohamed AF, Johnson FR, Cook M, Arrighi HM, Zhang J, Grundman M. Hauber AB, et al. Qual Life Res. 2014 Aug;23(6):1813-21. doi: 10.1007/s11136-013-0620-5. Epub 2014 Jan 22. Qual Life Res. 2014. PMID: 24448684

2

Risking health to avoid injections: preferences of Canadians with type 2 diabetes.

Hauber AB, Johnson FR, Sauriol L, Lescrauwaet B. Hauber AB, et al. Diabetes Care. 2005 Sep;28(9):2243-5. doi: 10.2337/diacare.28.9.2243. Diabetes Care. 2005. PMID: 16123499 No abstract available.

3

Are chemotherapy patients' HRQoL importance weights consistent with linear scoring rules? A stated-choice approach.

Johnson FR, Hauber AB, Osoba D, Hsu MA, Coombs J, Copley-Merriman C. Johnson FR, et al. Among authors: hauber ab. Qual Life Res. 2006 Mar;15(2):285-98. doi: 10.1007/s11136-005-0581-4. Qual Life Res. 2006. PMID: 16468083

4

Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.

Johnson FR, Ozdemir S, Manjunath R, Hauber AB, Burch SP, Thompson TR. Johnson FR, et al. Among authors: hauber ab. Med Care. 2007 Jun;45(6):545-52. doi: 10.1097/MLR.0b013e318040ad90. Med Care. 2007. PMID: 17515782

5

Older Americans' risk-benefit preferences for modifying the course of Alzheimer disease.

Hauber AB, Johnson FR, Fillit H, Mohamed AF, Leibman C, Arrighi HM, Grundman M, Townsend RJ. Hauber AB, et al. Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):23-32. doi: 10.1097/WAD.0b013e318181e4c7. Alzheimer Dis Assoc Disord. 2009. PMID: 18725862

6

Evaluation of the relative importance of chemotherapeutic and antiemetic efficacy in various oncologic settings.

Ettinger DS, Grunberg SM, Hauber AB, Mohamed AF. Ettinger DS, et al. Among authors: hauber ab. Support Care Cancer. 2009 Apr;17(4):405-11. doi: 10.1007/s00520-008-0501-6. Epub 2008 Sep 2. Support Care Cancer. 2009. PMID: 18762991

7

Benefits, risk, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatments.

Hauber AB, Mohamed AF, Watson ME, Johnson FR, Hernandez JE. Hauber AB, et al. AIDS Patient Care STDS. 2009 Jan;23(1):29-34. doi: 10.1089/apc.2008.0064. AIDS Patient Care STDS. 2009. PMID: 19113949

8

Who pays attention in stated-choice surveys?

Ozdemir S, Mohamed AF, Johnson FR, Hauber AB. Ozdemir S, et al. Among authors: hauber ab. Health Econ. 2010 Jan;19(1):111-8. doi: 10.1002/hec.1452. Health Econ. 2010. PMID: 19267358

9

Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.

Hauber AB, Mohamed AF, Johnson FR, Falvey H. Hauber AB, et al. Diabet Med. 2009 Apr;26(4):416-24. doi: 10.1111/j.1464-5491.2009.02696.x. Diabet Med. 2009. PMID: 19388973

10

Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications.

Hauber AB, Mohamed AF, Johnson FR, Meddis D, Wagner S, O'Dowd L. Hauber AB, et al. Allergy Asthma Proc. 2009 Mar-Apr;30(2):139-47. doi: 10.2500/aap.2009.30.3205. Allergy Asthma Proc. 2009. PMID: 19463204 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters